Additionally, our study of EA extract on oral cancer cells revealed that EA can inhibit the phosphorylation of Erk1/Erk2 and β-catenin, which could be behind the initiation of RELT/MET event and the overexpression of E-cadherin [12]. Here, MAPK1 is linked to lip and oral cavity carcinoma.